| 000 | 01681 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513025656.0 | ||
| 264 | 0 | _c19951129 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0026-2862 | ||
| 024 | 7 |
_a10.1006/mvre.1995.1039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOz, M C | |
| 245 | 0 | 0 |
_aAttenuation of microvascular permeability dysfunction in postischemic striated muscle by hydroxyethyl starch. _h[electronic resource] |
| 260 |
_bMicrovascular research _cJul 1995 |
||
| 300 |
_a71-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDextrans _xpharmacokinetics |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aFluorescein-5-isothiocyanate _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyethyl Starch Derivatives _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIschemia _xphysiopathology |
| 650 | 0 | 4 | _aMacromolecular Substances |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xblood supply |
| 650 | 0 | 4 |
_aNeutrophils _xcytology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred WF |
| 650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
| 700 | 1 | _aFitzPatrick, M F | |
| 700 | 1 | _aZikria, B A | |
| 700 | 1 | _aPinsky, D J | |
| 700 | 1 | _aDurán, W N | |
| 773 | 0 |
_tMicrovascular research _gvol. 50 _gno. 1 _gp. 71-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/mvre.1995.1039 _zAvailable from publisher's website |
| 999 |
_c7476051 _d7476051 |
||